Almac Diagnostics, EORTC Collaborate for Tumor Profiling

March 8, 2017

Almac Diagnostics has announced its selection by the EORTC as a partner for the molecular profiling of cancer patient samples.

Almac Diagnostics has announced its selection by the EORTC as a partner for the molecular profiling of cancer patient samples from their clinical trial data and that of pan-European Cancer network, SPECTA.

Read the full release here